IONQ 1-day forecast by Grok 4.5

The model's reasoning

(1) What you found, and where: Live quotes and history from Yahoo Finance (finance.yahoo.com/quote/IONQ and /history), StockAnalysis (stockanalysis.com/stocks/ionq/history), and Motley Fool show IONQ trading near $31.95 (intraday as of ~12:42-13:00 EDT on 2026-10-16, open $33.03, day range ~$31.87-$33.64, volume partial ~13-14M shares). Prior close 2026-10-15 was $34.35. Sources confirm NYSE regular-session USD pricing, volume in shares, split-adjusted OHLC.

(2) The current market regime as you read it: High-volatility growth stock in a dilution overhang after the $2B equity offering priced 2026-10-14 and the up-to-$1.3B all-stock Elisity acquisition announced 2026-10-12. Recent sessions show sharp swings (Oct 15 rebound +9.33% on heavy volume after Oct 14 -9.53% selloff). Technicals are weak short-term with price below recent averages and elevated beta (~3.3).

(3) Price range justification, with the levels and volatility you are using: Anchored to the ~$31.95 intraday quote. Recent daily ranges of $2-4 and 20-session high/low context (high near $47.91 Sep 28, low $30.03 Oct 15) plus typical post-dilution volatility support a $29.50-$34.50 band over the short window ending 2026-10-19. The range is asymmetric lower to reflect residual selling pressure outweighing the prior-day rebound.

(4) Scheduled or likely catalysts inside the window: No major scheduled events inside the 2026-10-16 to 2026-10-19 window. Recent verified catalysts (Cambridge Quantum Innovation Centre opening 2026-10-15, $2B equity raise, Elisity deal, DARPA Stage C) are already reflected; earnings estimated Nov 4. These are mainly sentiment/dilution driven rather than immediate fundamental resets.

(5) The strongest counter-argument, and what would invalidate your call: Strongest counter is the Oct 15 high-volume recovery from the dilution low and positive longer-term quantum narrative (DARPA, partnerships). Invalidation would be a sustained close back above the Oct 15 high near $34.36 on rising volume, indicating dilution absorption is complete.

(6) Why your confidence is the number it is: 42% reflects live but incomplete intraday data, high recent volatility, and the short post-catalyst window where direction is noisy; daily history is solid but partial-session volume precludes strong volume confirmation.

Daily OHLCV (last five completed sessions, oldest to newest; NYSE, USD, shares, split-adjusted): 2026-10-09 O 40.00 H 40.24 L 38.99 C 39.89 V 13255800; 2026-10-12 O 38.79 H 38.81 L 35.89 C 36.27 V 32151500; 2026-10-13 O 35.82 H 35.99 L 34.48 C 34.73 V 23468100; 2026-10-14 O 33.15 H 33.39 L 31.05 C 31.42 V 41353700; 2026-10-15 O 30.55 H 34.36 L 30.03 C 34.35 V 47972400. Sources: Yahoo Finance history, StockAnalysis. return_5d_pct ≈ -12.93% (34.35 / 39.45 - 1). high_20d ≈ 47.91, low_20d ≈ 30.03, avg_volume_20d ≈ 22.2M (arithmetic mean of available sessions). Venue NYSE, session US Eastern, currency USD, volume shares.

Catalyst assessment: Verified recent news centers on the $2B equity offering (priced at premium to prior close but still dilutionary) and Elisity acquisition; these primarily drive sentiment and share-count concerns rather than near-term revenue changes. Cambridge center and DARPA are positive but already known. No new verified catalyst inside the scored window.

Counter-evidence: Oct 15 close near the high of a wide range on above-average volume shows buyers stepped in after the dilution print, supporting possible continuation of the rebound rather than further decline.

Invalidation: A verified daily close above $34.36 (Oct 15 high) on volume exceeding the recent 20-session average would undermine the mild-bearish short-horizon view by confirming absorption of the offering overhang.

Intraday evidence at answering time: latest_price $31.95 USD, quote_time approximately 2026-10-16T16:42:00Z (EDT 12:42), source https://stockanalysis.com/stocks/ionq/history/ and Yahoo Finance, regular-session live/delayed. PARTIAL SESSION: open $33.03, high_so_far ~$33.64, low_so_far ~$31.87, cumulative_volume ~13-14M as of midday. Pre-event path showed the dilution selloff; observed reaction is the Oct 15 rebound partially given back intraday. Further move expected after current quote is modest downside or range-bound into the weekend/Monday as residual offering effects linger; relative intraday volume cannot be firmly established versus same-time baseline.

Other models on the same question

How this forecast is measured

Sends only the baseline price and the output format; your AI researches the asset itself. Best with a model that can search the web — it can reach news, filings and positioning we do not carry. Costs no market data, at generation or at settlement — you record the closing price yourself when the window shuts. The monthly allowance is what a membership buys, not a data bill.

Every model answering the same prompt is measured from the same starting price over the same window, and scored on its range and its call. How scoring works · All shared research.